Pharmafile Logo
Pharmafocus logo
Advanced Search
novartis_building

Breakthrough therapy designation for Novartis in advanced breast cancer treatment

August 3, 2016
Research and Development, Sales and Marketing Breakthrough Therapy Designation, FDA, LEE011, Novartis, ribociclib

Novartis has announced that the US Food and Drug Administration (FDA) has granted a breakthrough therapy designation to LEE011 (ribociclib) …

News
shire_image

Shire Q2 results outpace forecasts with 56% revenue growth

August 2, 2016
Research and Development, Sales and Marketing Baxalta, Shire, financial report

Shire has announced its fiscal results for Q2 2016, reporting a strong quarter with a 56% growth in total revenues …

News
pfizer_reflection

Revenue rises at Pfizer as Ibrance and Xeljanz beat sales expectations

August 2, 2016
Research and Development, Sales and Marketing 2016, Pfizer, Prevnar, Q2, Xeljanz, ibrance, results

Pfizer has published its Q2 results, which show revenues rising 11% with new drugs helping to drive the growth and …

News

Landmark UK ruling as judge rules PrEP can be funded on NHS

August 2, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Judge, NHS, PrEP, UK, available, ruling

A London high court judge has ruled in favour of a challenge brought by the National Aids Trust to allow …

News

Joint Article on Hydrogen Peroxide Efficacy Published in Letters in Applied Microbiology

August 2, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wickham laboratories

Wickham Laboratories Ltd is pleased to announce the publication of a joint study with Bioquell on the efficacy of disinfection …

News
Press release
eisa0002

Evaluation of Eisai’s advanced thyroid cancer treatment blocked until 2018 in England

August 2, 2016
Manufacturing and Production, Sales and Marketing CDF, Eisai, Lenvima, NHS, NICE, lenvatinib, thyroid cancer

Following negotiations between the NHS, NICE and Japanese pharmaceutical company Eisai, differentiated thyroid cancer (RAI-R DTC) drug lenvima (levatinib) has …

News
biogen_austria_238

Success for Biogen, Ionis as spinal muscular atrophy drug performs in Phase III

August 2, 2016
Manufacturing and Production, Research and Development Biogen, Ionis, phase III, spinal muscular atrophy

Biogen and Ionis Pharmaceuticals have announced that their spinal muscular atrophy treatment, nusinersen, met its primary endpoint at an interim …

News
pfizer_credit_flickr__ceiling

Pfizer expands gene therapy operations with acquisition of Bamboo Therapeutics

August 2, 2016
Manufacturing and Production, Research and Development Pfizer, acquisition, bamboo therapeutics, gene therapy

Pfizer has announced that it has acquired gene therapy biotech Bamboo Therapeutics for an initial $150 million, with potential milestone …

News
takeda_tokyo_hq

Phase III success for Takeda in lymphoma drug

August 1, 2016
Manufacturing and Production, Research and Development Adcetris, Seattle Genetics, Takeda, lymphoma

Takeda Oncology and Seattle Generic have announced new Phase III data for trial drug, Adcetris (brentuximab vedotin), in patients with …

News

FDA approves Shire’s haemophilia A treatment system

August 1, 2016
Manufacturing and Production, Research and Development FDA, Shire, adynovate, baxject, haemophilia

Shire has announced that the Food and Drug Administration (FDA) has approved the baxject III reconstitution system for adynovate [antihemophilic …

News
brexit

The impact of Brexit on the pharmaceutical industry: some preliminary considerations

August 1, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit

The outcome of the popular vote cast on 23 June 2016 will be remembered as the start of a new …

Feature

Sartorius doubles production capacity in UK with new facility

August 1, 2016
Manufacturing and Production, Sales and Marketing Princess Anne, Sartorius, UK, expansion

Pharmaceutical and laboratory equipment provider Sartorius has expanded operations at its Stonehouse site in Gloucestershire with a new plant, doubling …

News
merck_and_co

European Commission approves Zepatier for chronic hepatitis C infection

August 1, 2016
Research and Development, Sales and Marketing

MSD, known as Merck in the US and Canada, has announced that the European Commission has approved Zepatier (elbasvir/grazoprevir) with …

News

Surprise for Seres as shares sent tumbling by Phase II failure

August 1, 2016
Research and Development, Sales and Marketing FDA, clostrodium difficile, seres therapeutics

Seres Therapeutics has presented interim results from an ongoing Phase II trial which has sent company stock spiralling downward, as …

News
a_scientist_at_work_at_sanofis_immunology_laboratory_in_thailand

EMA accepts MMA for rheumatoid arthritis treatment Sarilumab

August 1, 2016
Research and Development, Sales and Marketing EMA, MAA, Regeneron, Sanofi, sarilumab

Sanofi and Regeneron Pharmaceuticals have announced that the European Medicines Agency (EMA) has accepted the Marketing Authorisation Application (MAA) for …

News
GSK image

GSK and Alphabet to create bioelectronics medicines in £540 million partnership

August 1, 2016
Research and Development, Sales and Marketing Alphabet, GSK, Verily, bioelectronic medicine, galvani, google

GlaxoSmithKline and Verily Life Sciences, a division of Google’s parent company Alphabet, have announced a £540 million partnership that will …

News
antiviralresearch

FDA fast tracks Shire’s SHP626 nonalcoholic steatohepatitis drug

July 29, 2016
Research and Development FDA, SHP626, Shire, liver fibrosis, nash, volixibat, volxibat

The Food and Drug Administration (FDA) has granted Fast Track designation to Shire’s SHP626 (volixibat) treatment for patients suffering from …

News
humacao_exterior

Bristol-Myers Squibb grows revenues 17% to $4.9 billion in Q2 2016

July 29, 2016
Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, finance, opdivo

Bristol-Myers Squibb has announced its financial results for the second quarter of 2016, noting sizeable year-on-year sales growth and leaps …

News

China’s Fosun seals $1.3 billion deal for Gland Pharma

July 29, 2016
Medical Communications, Sales and Marketing acquisition, fosun, gland, takeover

Fosun Pharmaceutical has agreed a deal to purchase an 86.1% stake of Gland Pharma, which will see the Chinese firm …

News

Ulcerative colitis treatment Xeljanz records positive top-line results in Phase III trial

July 29, 2016
Medical Communications, Research and Development Pfizer, Xeljanz, tofacitinib, ulcerative colitis

Pfizer has announced positive top-line results from oral clinical trials for tofacitinib in ulcerative colitis (Octave) sustain, the third Phase …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026